Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIV-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 10887 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. Romano, L; Venturi, G; Vivarelli, A; Galli, L; Zazzi, M
      Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple

      CLINICAL INFECTIOUS DISEASES
    3. Andreoletti, L; Lescieux, A; Lambert, V; Si-Mohamed, A; Matta, M; Wattre, P; Belec, L
      Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy

      JOURNAL OF MEDICAL VIROLOGY
    4. Grant, MD
      Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections

      JOURNAL OF MEDICAL VIROLOGY
    5. Casimiro, DR; Tang, AM; Perry, HC; Long, RS; Chen, MC; Heidecker, GJ; Davies, ME; Freed, DC; Persaud, NV; Dubey, S; Smith, JG; Havlir, D; Richman, D; Chastain, MA; Simon, AJ; Fu, TM; Emini, EA; Shiver, JW
      Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

      JOURNAL OF VIROLOGY
    6. Martin-Serrano, J; Li, K; Bieniasz, PD
      Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes

      JOURNAL OF VIROLOGY
    7. Moore, AC; Kong, WP; Chakrabarti, BK; Nabel, GJ
      Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

      JOURNAL OF VIROLOGY
    8. Evans, DT; Tillman, KC; Desrosiers, RC
      Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor

      JOURNAL OF VIROLOGY
    9. Igarashi, T; Brown, CR; Byrum, RA; Nishimura, Y; Endo, Y; Plishka, RJ; Buckler, C; Buckler-White, A; Miller, G; Hirsch, VM; Martin, MA
      Rapid and irreversible CD4(+) T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIVDH12R is systemic and synchronous

      JOURNAL OF VIROLOGY
    10. Trask, SA; Derdeyn, CA; Fideli, U; Chen, YL; Meleth, S; Kasolo, F; Musonda, R; Hunter, E; Gao, F; Allen, S; Hahn, BH
      Molecular epidemiology of human immunodeficiency virus type 1 transmissionin a heterosexual cohort of discordant couples in Zambia

      JOURNAL OF VIROLOGY
    11. Ortiz, GM; Hu, J; Goldwitz, JA; Chandwani, R; Larsson, M; Bhardwaj, N; Bonhoeffer, S; Ramratnam, B; Zhang, LQ; Markowitz, MM; Nixon, DF
      Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection

      JOURNAL OF VIROLOGY
    12. Reed, M; Mariani, R; Sheppard, L; Pekrun, K; Landau, NR; Soong, NW
      Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells

      JOURNAL OF VIROLOGY
    13. Kattan, M; Platzker, A; Mellins, RB; Schluchter, MD; Chen, XC; Peavy, H; Steinbach, S; Wohl, ME; Hiatt, P; Hunter, J; Colin, AA
      Respiratory diseases in the first year of life in children born to HIV-1-infected women

      PEDIATRIC PULMONOLOGY
    14. Mekapati, SB; Sivakumar, R; Gupta, SP
      Quantitative structure-activity relationship of some HIV-1 protease inhibitors: A Fujita-Ban type analysis

      JOURNAL OF ENZYME INHIBITION
    15. Deng, C; Saunders, WS
      RIM4 encodes a meiotic activator required for early events of meiosis in Saccharomyces cerevisiae

      MOLECULAR GENETICS AND GENOMICS
    16. Goldfarb, M
      Analysis of antibody to milk proteins in HIV positive/negative sera using two-dimensional electrophoresis, Western blot and immunoassay

      PROTEOMICS
    17. Tian, HJ; Xiao, Y; Zhu, M; Chen, YH
      HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

      INTERNATIONAL IMMUNOPHARMACOLOGY
    18. Chae, H; Chae, S; Park, N; Bang, B; Cho, S; Kim, J; Kim, H; Kim, H; Lee, Z; Kim, H
      Pyrrolidine dithiocarbamate inhibits serum-induced NF-kappa B activation and induces apoptosis in ROS 17/2.8 osteoblasts

      INTERNATIONAL IMMUNOPHARMACOLOGY
    19. Waldrop, D; Kumar, M; Kumar, AM; Wilkie, FL; Eisdorfer, C
      Mirror star-tracing performance in HIV-1 infection: an assessment of visuoconstructive skills?

      STRESS AND HEALTH
    20. Murphy, PM
      Viral exploitation and subversion of the immune system through chemokine mimicry

      NATURE IMMUNOLOGY
    21. Cunha, AC; Pereira, LOR; de Souza, ROP; de Souza, MCBV; Ferreira, VF
      Synthesis of 4-acyl-1H-1,2,3-triazolic nucleosides

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    22. Darfeuille, F; Cazenave, C; Gryaznov, S; Duconge, F; Di Primo, C; Toulme, JJ
      RNA and N3 -> P5 ' kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    23. Naeger, LK; Margot, NA; Miller, MD
      Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    24. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Deeks, SG; Barditch-Crovo, P; Collier, A; Smith, A; Miller, M; McGowan, M; Coakley, DF
      Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Dunne, EF; Angoran-Benie, H; Kamelan-Tano, A; Sibailly, TS; Monga, BB; Kouadio, L; Roels, TH; Wiktor, SZ; Lackritz, EM; Mintz, ED; Luby, S
      Is drinking water in Abidjan, Cote d'Ivoire, safe for infant formula?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Ghani, AC; de Wolf, F; Ferguson, NM; Donnelly, CA; Coutinho, R; Miedema, F; Goudsmit, J; Anderson, RM
      Surrogate markers for disease progression in treated HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Fontaine, E; Riva, C; Peeters, M; Schmit, JC; Delaporte, E; Van Laethem, K; Van Vaerenbergh, K; Snoeck, J; Van Wijngaerden, E; De Clercq, E; Van Ranst, M; Vandamme, AM
      Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Delbeke, E
      HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Ben Halima, M; Pasquier, C; Slim, A; Ben Chaabane, T; Arrouji, Z; Puel, J; Ben Redjeb, S; Izopet, J
      First molecular characterization of HIV-1 Tunisian strains

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Marmor, M; Sheppard, HW; Donnell, D; Bozeman, S; Celum, C; Buchbinder, S; Koblin, B; Seage, GR
      Homozygous and heterozygous CCR5-Delta 32 genotypes are associated with resistance to HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Balotta, C; Facchi, G; Violin, M; Van Dooren, S; Cozzi-Lepri, A; Forbici, F; Bertoli, A; Riva, C; Senese, D; Caramello, P; Carnevale, G; Rizzardini, G; Cremonini, L; Monno, L; Rezza, G; Perno, CF; Ippolito, G; d'Arminio-Monforte, A; Vandamme, AM; Moroni, M
      Increasing prevalence of non-clade BHIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Roberts, DE; Ribeiro, RM
      Comparison of different treatment regimens for the emergence of new resistance under therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Mwachari, CW; Cohen, CR; Meier, AS; Nganga, LW; Kimari, JN; Odhiambo, JA
      Respiratory tract infection in HIV-1-infected adults in Nairobi, Kenya - Evaluation of risk factors and the World Health Organization treatment algorithm

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Harouse, JM; Gettie, A; Tan, RCH; Eshetu, T; Ratterree, M; Blanchard, J; Cheng-Mayer, C
      Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIVSF33A2 map to env region

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    41. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
      Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    42. Bisset, LR; Cone, RW; Fischer, M; Battegay, M; Vernazza, PL; Dubs, RW; Weber, R; Grob, PJ; Opravil, M
      Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    43. Wilson, TE; Minkoff, H
      Condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    44. Vittinghoff, E; Hessol, NA; Becchetti, P; Fusaro, RE; Holmberg, SD; Buchbinder, SP
      Cofactors for HIV disease progression in a cohort of homosexual and bisexual men

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    45. Masquelier, B; Chaix, ML; Burgard, M; Lechenadec, J; Doussin, A; Simon, F; Cottalorda, J; Izopet, J; Tamalet, C; Douard, D; Fleury, H; Mayaux, MJ; Blanche, S; Rouzioux, C
      Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    46. Nicholson, JKA; Browning, SW; Hengel, RL; Lew, E; Gallagher, LE; Rimland, D; McDougal, JS
      CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    47. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    48. Lu, J; Kuritzkes, DR
      A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    49. Lai, H; Lai, SH; Shor-Posner, G; Ma, FC; Trapido, E; Baum, MK
      Plasma zinc, copper, copper : zinc ratio, and survival in a cohort of HIV-1-infected homosexual men

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    50. Lemiale, F; Brand, D; Lebigot, S; Verrier, T; Buzelay, L; Brunet, S; Barin, F
      Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates - A comparative study using multivalent vaccine approaches

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    51. Coull, JJ; Turner, D; Melby, T; Betts, MR; Lanier, R; Margolis, DM
      A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    52. Rogers, AS; Lindsey, JC; Donfield, S; D'Angelo, LJ
      HIV-1 RNA levels and development of clinical disease in two different adolescent populations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    53. Daar, ES; Lynn, H; Donfield, S; Gomperts, E; Hilgartner, MW; Hoots, WK; Chernoff, D; Arkin, S; Wong, WY; Winkler, CA
      Relation between HIV-1 and hepatitis C viral load in patients with hemophilia

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    54. Lewden, C; Raffi, F; Chene, G; Sobel, A; Leport, C
      Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy - Standardization to the general population

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    55. Hendel, H; Winkler, C; An, P; Roemer-Binns, E; Nelson, G; Haumont, P; O'Brien, S; Khalilli, K; Zagury, D; Rappaport, J; Zagury, JF
      Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    56. Aung, H; McKenna, SM; Ketoff, NR; Jones, L; Wu, M; Hejal, R; Rich, EA; Toossi, Z
      Dysregulation of beta-chemokines in the lungs of HIV-1-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    57. Kost, RG; Hurley, A; Zhang, LQ; Vesanen, M; Talal, A; Furlan, S; Caldwell, P; Johnson, J; Smiley, L; Ho, D; Markowitz, M
      Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    58. Trichavaroj, R; de Souza, MS; Buapunth, P; Markowitz, L; Sukwit, S; Nitayaphan, S; Brown, AE
      HIV viral load in Thai men and women with subtype E infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    59. Baeten, JM; Mostad, SB; Hughes, MP; Overbaugh, J; Bankson, DD; Mandaliya, K; Ndinya-Achola, JO; Bwayo, JJ; Kreiss, JK
      Selenium deficiency is associated with shedding of HIV-1-infected cells inthe female genital tract

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    60. Lai, S; Liu, W; Chen, J; Yang, J; Li, ZJ; Li, RJ; Liang, FX; Liang, SL; Zhu, QY; Yu, XF
      Changes in HIV-1 incidence in heroin users in Guangxi Province, China

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    61. Parry, JV; Murphy, G; Barlow, KL; Lewis, K; Rogers, PA; Belda, FJ; Nicoll, A; McGarrigle, C; Cliffe, S; Mortimer, PP; Clewley, JP
      National surveillance of HIV-1 subtypes for England and Wales - Design, methods, and initial findings

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    62. Saha, K; Zhang, JC; Zerhouni, B
      Evidence of productively infected CD8(+) T cells in patients with AIDS: Implications for HIV-1 pathogenesis

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    63. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
      Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    64. Chen, YMA; Huang, KL; Jen, I; Chen, SC; Liu, YC; Chuang, YC; Wong, JC; Tsai, JJ; Lan, YC
      Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    65. Barbouche, RM; Hong, L; Dellagi, K; Kostrikis, LG
      Contrasting frequencies of CCR5 Delta 32 and CCR2-64I alleles in the Tunisian population

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    66. Tchetgen, E; Kaplan, EH; Friedland, GH
      Public health consequences of screening patients for adherence to highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    67. John, GC; Sheppard, H; Mbori-Ngacha, D; Nduati, R; Maron, D; Reiner, M; Kreiss, J
      Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    68. de Martino, M; Galli, L; Moriondo, M; Zazzi, M; Azzari, C; Peruzzi, M; Vierucci, A
      Dissociation of responses to highly active antiretroviral therapy: Notwithstanding virologic failure and virus drug resistance, both CD4(+) and CD8(+) T lymphocytes recover in HIV-1 perinatally infected children

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    69. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    70. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
      Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    71. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
      Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    72. Kleeberger, CA; Phair, JP; Strathdee, SA; Detels, R; Kingsley, L; Jacobson, LP
      Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    73. Reisler, RB; Thea, DM; Pliner, V; Green, T; Lee, F; Nesheim, S; Brown, T; Kalish, M; Folks, TM; Heneine, W
      Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: A comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    74. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    75. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    76. Tarantal, AF; Lee, CI; Ekert, JE; McDonald, R; Kohn, DB; Plopper, CG; Case, SS; Bunnell, BA
      Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): Lung-targeting approaches

      MOLECULAR THERAPY
    77. Thaler, S; Schnierle, BS
      A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes

      MOLECULAR THERAPY
    78. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
      Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1

      MOLECULAR THERAPY
    79. Pfeifer, A; Kessler, T; Yang, M; Baranov, E; Kootstra, N; Cheresh, DA; Hoffman, RM; Verma, IM
      Transduction of liver cells by lentiviral vectors: Analysis in living animals by fluorescence imaging

      MOLECULAR THERAPY
    80. Tarantal, AF; O'Rourke, JP; Case, SS; Newbound, GC; Li, J; Lee, CI; Baskin, CR; Kohn, DB; Bunnell, RA
      Rhesus monkey model for fetal gene transfer: Studies with retroviral-basedvector systems

      MOLECULAR THERAPY
    81. Decicco, CP; Song, Y; Evans, DA
      Intramolecular O-arylation of phenols with phenylboronic acids: Application to the synthesis of macrocyclic metalloproteinase inhibitors

      ORGANIC LETTERS
    82. Liu, SF; Dockendorff, C; Taylor, SD
      Synthesis of protected L-4-[sulfono(difluoromethyl)]phenylalanine and its incorporation into a peptide

      ORGANIC LETTERS
    83. Lunney, EA
      Computing in drug discovery: The design phase

      COMPUTING IN SCIENCE & ENGINEERING
    84. Le, YY; Wetzel, MA; Shen, WP; Gong, WH; Rogers, TJ; Henderson, EE; Wang, JM
      Desensitization of chemokine receptor CCR5 in dendritic cells at the earlystage of differentiation by activation of formyl peptide receptors

      CLINICAL IMMUNOLOGY
    85. Szabo, J; Cervenak, L; Toth, FD; Prohaszka, Z; Horvath, L; Kerekes, K; Beck, Z; Bacsi, A; Erdei, A; Peerschke, EIB; Fust, G; Ghebrehiwet, B
      Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures

      CLINICAL IMMUNOLOGY
    86. Salkowitz, JR; Purvis, SF; Meyerson, H; Zimmerman, P; O'Brien, TR; Aledort, L; Eyster, ME; Hilgartner, M; Kessler, C; Konkle, BA; White, GC; Goedert, JJ; Lederman, MM
      Characterization of high-risk HIV-1 seronegative hemophiliacs

      CLINICAL IMMUNOLOGY
    87. Messele, T; Brouwer, M; Girma, M; Fontanet, AL; Miedema, F; Hamann, D; de Wit, TFR
      Plasma levels of viro-immunological markers in HIV-infected and noninfected ethiopians: Correlation with cell surface activation markers

      CLINICAL IMMUNOLOGY
    88. Martin, K; Heinzlmann, M; Borchers, R; Mack, M; Loeschke, K; Folwaczny, C
      Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease

      CLINICAL IMMUNOLOGY
    89. Patel, DD; Zachariah, JP; Whichard, LP
      CXCR3 and CCR5 ligands in rheumatoid arthritis synovium

      CLINICAL IMMUNOLOGY
    90. Anderson, DE; Carlos, MP; Nguyen, L; Torres, JV
      Overcoming original (antigenic) sin

      CLINICAL IMMUNOLOGY
    91. Dyrhol-Riise, AM; Stent, G; Rosok, BI; Voltersvik, P; Olofsson, J; Asjo, B
      The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissueduring highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    92. Dyrhol-Riise, AM; Ohlsson, M; Skarstein, K; Nygaard, SJT; Olofsson, J; Jonsson, R; Asjo, B
      T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    93. de Martino, M; Chiarelli, F; Moriondo, M; Torello, M; Azzari, C; Galli, L
      Restored antioxidant capacity parallels the immunologic and virologic improvement in children with perinatal human immunodeficiency virus infection receiving highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    94. Kalinkovich, A; Borkow, G; Weisman, Z; Tsimanis, A; Stein, M; Bentwich, Z
      Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors

      CLINICAL IMMUNOLOGY
    95. Zhou, RH; Friesner, RA; Ghosh, A; Rizzo, RC; Jorgensen, WL; Levy, RM
      New linear interaction method for binding affinity calculations using a continuum solvent model

      JOURNAL OF PHYSICAL CHEMISTRY B
    96. Olsen, AG; Nielsen, C; Wengel, J
      Synthesis and evaluation of anti-HIV activity of 3-azido-4-(hydroxymethyl)tetrahydrofuran derivatives containing 2-(thymin-1-yl)methyl, 2-(cytosin-1-yl)methyl or 2-(adenin-9-yl)methyl substituents - a new series of AZT analogues

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    97. O'Brien, SJ; Gao, XJ; Carrington, M
      HLA and AIDS: a cautionary tale

      TRENDS IN MOLECULAR MEDICINE
    98. Goronzy, JJ; Weyand, CM
      Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis

      TRENDS IN IMMUNOLOGY
    99. Appay, V; Rowland-Jones, SL
      RANTES: a versatile and controversial chemokine

      TRENDS IN IMMUNOLOGY
    100. Accolla, RS; Barbaro, AD; Mazza, S; Casoli, C; De Maria, A; Tosi, G
      The MHC class II transactivator: prey and hunter in infectious diseases

      TRENDS IN IMMUNOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 13:18:42